StockData
Immunome Inc. logo

Immunome Inc. (IMNM) income statement

IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$15.69−0.92 (-5.54%)

Close on Nov 20, 2026Market cap $1.78BP/E –Yield –

See a number that looks wrong?